BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Bio » Author » Andrea K. Miyahira, PhD
Dr. Andrea Miyahira has a PhD in cancer immunology, and is Director of Research at the Prostate Cancer Foundation.